Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Three Asoprisnil Doses in the Treatment of Women With Endometriosis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and effectiveness of three doses of asoprisnil in women with endometriosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Asoprisnil (asoprisnil)

Snippet

Sponsor: Abbott | Conditions: Endometriosis | Phase 2 | Status: COMPLETED